RGC CIK: 1829667

Regencell Bioscience Holdings Ltd

  • Hong Kong
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
Change from FY22 to FY26
millions USD
FY22:
−5.27
FY23:
−4.96
FY24:
−4.00
FY25:
−3.11
FY26:
−7.70
Change from FY22 to FY26
millions USD
FY22:
−10.8
FY23:
0.06
FY24:
5.24
FY25:
2.69
FY26:
2.50
Change from FY22 to FY26
millions USD
FY22:
22.4
FY23:
0.13
FY24:
0.10
FY25:
–
FY26:
16.9
millions USD
FY22:
6.36
FY23:
−4.85
FY24:
1.40
FY25:
−0.54
FY26:
11.8
(positive)
Change from FY22 to FY25
millions USD
FY22:
−6.05
FY23:
−4.99
FY24:
−4.01
FY25:
−3.27
FY26:
–

All amounts in millions USD Data source:SEC EDGAR